Clinical Trials Insight: 700028884

Trial Profile

Clinical Trials Insight: 700028884

Phase of Trial: Phase I

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Auriclosene (Primary)
  • Indications Conjunctivitis; Otorhinolaryngological infections; Staphylococcal infections; Urinary tract infections
  • Focus Adverse reactions
  • Sponsors NovaBay Pharmaceuticals
  • Most Recent Events

    • 04 Dec 2013
    • 11 Mar 2008 Status changed from recruiting to completed, as reported in a NovaBay media release.
    • 28 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top